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Introduction: Fournier’s gangrene is an infectious necrotizing fasciitis of the perineum and genital regions and has
a high mortality rate. It is a synergistic infection caused by a mixture of aerobic and anaerobic organisms and
predisposing factors, including diabetes mellitus, alcoholism, malnutrition, and low socioeconomic status. We report
a case of Fournier’s gangrene in a patient with unknown type II diabetes submitted to 24-hour catheterization
15 days before gangrene onset.
Case presentation: The patient, a 60-year-old Caucasian man, presented with a swollen, edematous,
emphysematous scrotum with a crepitant skin and a small circle of necrosis. A lack of resistance along the dartos
fascia of the scrotum and Scarpa’s lower abdominal wall fascia combined with the presence of gas and pus during
the first surgical debridement also supported the diagnosis of Fournier’s gangrene. On the basis of the
microbiological culture, the patient was given multiple antibiotic therapy, combined hypoglycemic treatment,
hyperbaric oxygen therapy, and several surgical debridements. After five days the infection was not completely
controlled and a vacuum-assisted closure device therapy was started.
Conclusions: This report describes the successful multistep approach of an immediate surgical debridement
combined with hyperbaric oxygen and negative pressure wound therapy. The vacuum-assisted closure is a
well-known method used to treat complex wounds. In this case study, vacuum-assisted closure treatment was
effective and the patient did not require reconstructive surgery. Our report shows that bladder catheterization, a
minimally invasive maneuver, may also cause severe infective consequences in high-risk patients, such as patients
with diabetes.
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Figure 1 Total exposure of the testes after scrotal debridement.
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We present a case of Fournier’s gangrene in a patient
with an unknown type II diabetes mellitus who was given
a 24-hour catheterization 15 days before gangrene onset.
The aim of this report is to describe our clinical expe-
rience regarding patients with Fournier’s gangrene treated
with vacuum-assisted closure (VAC) and to clarify the
increased risk of a severe infection secondary to minimally
invasive urological procedures, such as catheterization, in
patients with uncontrolled diabetes.
Fournier’s gangrene, an infective necrotizing fasciitis, is
a severe condition with high morbidity and mortality. Pre-
disposing factors include various states of immunosup-
pression, such as diabetes mellitus, chronic alcoholism,
acquired immune deficiency syndrome, and malnutrition
[1-3]. The pathology was first described in 1883 by Jean
Alfred Fournier who presented five male diabetic patients
with fulminating gangrene of the genitalia [4]. Fournier’s
gangrene is caused by normal skin commensals of the
perineum and genitalia that act synergistically to cause in-
fection and invade the tissue, causing microthrombosis of
the small subcutaneous vessels leading to ischemia. Va-
rious cytotoxic agents (for example, collagenases, and
streptokinases) are released at the gangrene site and cause
the progressive destruction of local tissue. Therefore, good
management is based on aggressive debridement, broad-
spectrum antibiotic therapy, and intensive supportive care.
This report describes the successful use of a multistep
approach, including negative-pressure wound therapy, in
a case of Fournier’s gangrene developed in a patient with
an unknown type II diabetes mellitus.
Case presentation
In 2011 a 60-year-old Caucasian man was admitted to
the Emergency Department of our hospital due to scro-
tal and perineal pain and fever (39°C). Blood analysis
showed the following: leukocytosis (14.47×103/mm3),
glucose 417mg/dL, creatinine 1.55mg/dL, sodium
136mmol/L, potassium 4.1mmol/L, hematocrit 37.2g/dL,
bicarbonate 26mmol/L, total protein 5.1g/dL, and albumin
3.2g/dL. The coagulation parameters were fibrinogen
594mmol/L, partial thromboplastin time 31 seconds,
prothombin time-international normalized ratio 1.18, and
platelet count 255×103/mm3. Ultrasonography of the
patient’s scrotum showed the bilateral presence of micro-
bubbles, purulent corpuscular material suggestive for ab-
scess, and a subcutaneous inguinal edema.
At physical examination the patient appeared obese,
with a body mass index (BMI) of 31.8; the scrotum pre-
sented with a swollen, edematous, emphysematous and
crepitant skin with a small circle of necrosis. In his cli-
nical history the patient reported that 15 days prior he
had been admitted to the emergency department of ano-
ther hospital due to abdominal pain and was catheterizedfor 24 hours, then discharged with the diagnosis of bowel
subocclusion.
We submitted the patient to surgical treatment, which
consisted of abdominal wall debridement including the in-
guinal region and scrotum (Figure 1). A lack of resistance
along the dartos fascia of the scrotum and Scarpa’s fascia
of the lower abdominal wall, as well as minimal bleeding
and the presence of gas and pus, were important signs to
support the diagnosis of Fournier’s gangrene. Surgical
management included wide tissue incisions to allow abun-
dant washing with hydrogen peroxide and saline solution.
One subcutaneous trans-scrotal drainage and two sub-
cutaneous suprapubic drainages were inserted. After sur-
gery, an abdominal and pelvic computed tomography
(CT) scan showed a right channel inguinal patchy area
with predominantly soft tissue density, suggestive for ab-
scess, with evidence of numerous gas microbubbles in
contiguity with the scrotum. After the first surgical
debridement, a microbiological culture was taken from
the tissue sample. A single microorganism was isolated
(Group A streptococcus), and antibiotic therapy was
adapted to the antibiogram (daptomycin 500mg, piperacil-
lin sodium-tazobactam sodium 4.5mg three times/day,
Figure 2 Exposure of the wound at the time of discharge.
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association with electrolyte replacement.
The diagnosis of diabetes mellitus was confirmed by
glycated hemoglobin measurement (7.5%, 59mmol/mol),
and five days after surgery, a scheduled combined thera-
peutic protocol with intermediate acting insulin and oral
therapy (metformin 850mg twice/day) finally controlled
glucose blood levels.
Debridements were repeated every 24 to 48 hours, and
the patient was submitted to 14 sessions of hyperbaric
oxygen (HBO) therapy (20 minutes each at 2.4 atmos-
phere absolute, 100% fraction of inspired oxygen), but
the infection was not still completely controlled.
It was then decided to add a new adjuvant treatment –
VAC therapy – already in use for diabetic foot ulcers, com-
plex wounds, and abscesses involving the abdominal and
chest wall. This VAC therapy (KCI, San Antonio, TX, USA)
is a polyurethane sponge cut to the appropriate size and
placed over the wound. The sponge, with a suction tube, is
covered with a second sterile, adherent, occlusive dressing.
Suction is applied to the sponge using a portable pump.
The dressing needs to be changed every 24 to 72 hours.
The most important benefits of this therapy include a
reduction in the wound area together with induction of
new granulation tissue, effective wound cleaning, and
the continuous removal of wound exudate. After 21 days
of VAC therapy, the wound was stabilized, fresh granula-
tion tissue formed with a consequent resorption of the
gas microbubbles (confirmed on the next abdominal and
pelvic CT), and an important neovascularization of the
wound was observed (18 days after hospital admittance).
The VAC treatment was so effective that the patient did
not require reconstructive surgery. The patient was dis-
charged one month after hospital admission (34 days) with
the surgical wound almost completely healed (Figure 2),
normal blood glucose levels, and a BMI of 28.7.
Discussion
Considering the high mortality rate of up to 40%, Fournier’s
gangrene, although rare, should be immediately recog-
nized and treated, particularly in patients with predispos-
ing factors, such as autoimmune diseases, alcoholism, low
socioeconomic status, intravenous drug use, cancer, and
diabetes mellitus [5,6].
Emergency surgical removal of all affected tissue is the
primary mandatory treatment even though several
repeated debridements might be necessary [5]. However,
surgery represents only the first step of a multidiscipli-
nary approach, which involves a urologist, general and
plastic surgeon, microbiologist, and nutritionist [7]. Ad-
juvant treatments include the use of HBO, which has
been reported to reduce Fournier’s gangrene mortality
compared to exclusive surgical debridement. Optimal tis-
sue oxygenation, obtained by HBO therapy, potentiatesthe host’s bactericidal mechanisms and wound-healing
activity. Furthermore, HBO therapy has a direct toxic
effect on anaerobic bacteria [8,9]. Another important
adjunctive treatment reported in the literature is VAC,
which is currently used for wound complications and is
an easy and reliable method that significantly promotes
better healing. The negative pressure applied by the de-
vice on the wound removes exudates, securely covers the
wound, stimulates angiogenesis, and reduces bacterial
contamination [10].
Although the use of VAC is not considered a standard
approach for Fournier’s gangrene, HBO may have more
beneficial effects if combined with a reduction of edema
and interstitial pressure achieved by the VAC dressing [11].
Our experience supports this evidence, confirming that
the association of VAC therapy with the common thera-
peutic schedule (surgical debridement, broad-spectrum
antibiosis, and HBO) can improve the prognosis of these
patients by reducing the recovery time and the need for
reconstructive surgery.Conclusions
We confirm the benefits of a multistep therapeutic ap-
proach (surgery, HBO, and VAC therapy) and suggest
this combination as a scheduled effective therapeutic
protocol. This clinical case report shows that minimally
invasive maneuvers, such as bladder catheterization, may
have severe infective consequences in high-risk patients,
such as those with diabetes. Surgeons need to be aware
of the clinical signs of Fournier’s gangrene and to act
promptly given the high mortality rate of the disease.
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for the publication of this case report and any accompany-
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review by the Editor-in-Chief of this journal.
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